Fundraising Fox
Gritstone Oncology
San Carlos, US · Founded 2015 · 27 employees on LinkedIn · 11 known investors
Find your way into Gritstone Oncology
Sign up to see every warm intro you have to Gritstone Oncology
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Gritstone Oncology team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Nexoplex Bio develops immunotherapies that target tumor cells through recognition of HLA-peptide complexes using multi-specific antibodies, addressing tumor types including lung, gastric, esophageal, head and neck, cervical cancers, and lung squamous cell carcinoma. The company works at the intersection of cancer genomics and immunotherapy and is based at MBC Biolabs in San Carlos, California.
Founders & leadership
Investors · 11
How we know: GV (Google Ventures)'s portfolio page · funding news · biospace.com · Not right? Tell us
How we know: funding news · biospace.com · the VCSheet dataset · Not right? Tell us
How we know: biospace.com · Not right? Tell us
Also in the syndicate · 3
Funding
SEC filings, press & company announcements$92.7M disclosed across 1 round · 2017
- $92.7MSeries BSep 2017 · 3 sources
Lilly Asia Ventures (lead), Alexandria Venture Investments, Clarus Funds, Frazier Healthcare Partners, GV, The Column Group, Trinitas Capital, Trinitas Capital (Beijing), Versant Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Gritstone Oncology do?
- Nexoplex Bio develops immunotherapies that target tumor cells through recognition of HLA-peptide complexes using multi-specific antibodies, addressing tumor types including lung, gastric, esophageal, head and neck, cervical cancers, and lung squamous cell carcinoma. The company works at the intersection of cancer genomics and immunotherapy and is based at MBC Biolabs in San Carlos, California.
- Who are Gritstone Oncology's investors?
- Gritstone Oncology's investors include Bay City Capital, GV (Google Ventures), LAV, Lilly Asia Ventures, Alexandria, Frazier Healthcare Partners, The Column Group, Versant Ventures.
- How much funding has Gritstone Oncology raised?
- Gritstone Oncology has disclosed $92.7M raised across 1 round.
- Where is Gritstone Oncology headquartered?
- Gritstone Oncology is headquartered in San Carlos, US.